Abstract Submission: “Anti-diabetic efficacy of Fenfuro, a novel, patented Trigonella foenum-graecum seed extract (1019.14)”
http://www.fasebj.org/content/28/1_Supplement/1019.14
Abstract Submission: “Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)”
http://www.tandfonline.com/doi/abs/10.3109/15376516.2014.943443
Abstract Submission: “Efficacy Evaluation Of Fenfuro In Diabetes Type Ii Rat Model.”
http://www.sciipub.com/index.php/forum/2-international-journal-of-pharmacology-a-toxicology-science-issn-2249-4502/586-efficacy-evaluation-of-fenfuro-in-diabetes-type-ii-rat-model-kiran-tiwari
Abstract Submission: “Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)”
http://www.academia.edu/8454503/Safety_efficacy_and_toxicological_evaluation_of_a_novel_patented_anti-diabetic_extract_of_Trigonella_Foenum-Graecum_seed_extract_Fenfuro
Outstanding Contributions to National Development Award
We are glad to inform that our Company has been awarded OUTSTANDING CONTRIBUTION TO NATIONAL DEVELOPMENT
India SME top 100 awards
Our company has been declared a WINNER in overall evaluation for INDIA SME TOP 100 AWARDS amongst 49023 nominations.
Selected as a FINALIST in NutraIngredients Awards
We are pleased to inform that our product Furocyst( For management of Polycystic Ovary syndrome) has been selected as a FINALIST in NutraIngredients Awards for “FINISHED PRODUCT OF THE YEAR – MEDICAL FOODS, 2016”. The ceremony will take place on 11th May 2016 at the Vitafood Europe (Starling Hotel, in Geneva, Switzerland).
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH TYPE-2 DIABETES
Poster Presentation on “CLINICAL EVALUATION OF FENFURO (FUROSTANOLIC SAPONINS) IN PATIENTS WITH TYPE-2 DIABETES” at 6th World Congress of Diabetes India held on 9thto 12thApril at Hotel ITC Grand Chola Convention Centre Chennai.
Poster presentation at Diabetes UK Professional Conference
Poster Presented on “A Muti-centric placebo-controlled double-blind clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum, FENFUROTM) extract in patients with Type-2 diabtes: an add-on study at Diabetes UK Professional Conference, Glasgow, UK on 2-4 March 2016.
Newly diagnosed diabetics have 1-year time to control BP without drugs
Washington, Jan 10 : Middle-aged adults who are recently diagnosed with diabetes and hypertension have at least one year time to try to learn how to control their high blood pressure without medications, but further delay can increase damage, a new study has suggested. The consequences of delaying effective hypertension treatment for up to a…